Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors

This study has been terminated.
Sponsor:
Information provided by:
SGX Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00606879
First received: January 18, 2008
Last updated: July 22, 2008
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2009
  Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)